Hormone Therapy

Latest News

Use of testosterone does not lead to abnormal hematocrit levels
Use of testosterone does not lead to abnormal hematocrit levels

November 27th 2023

"The findings from this study represent very important reassurance regarding the safety of testosterone as masculinizing treatment," says Joshua Safer, MD, FACP, FACE.

Study highlights how DTC online platforms often fail to convey risks of testosterone therapy
Study highlights how DTC online platforms often fail to convey risks of testosterone therapy

December 8th 2022

FDA approves oral testosterone replacement therapy for hypogonadism
FDA approves oral testosterone replacement therapy for hypogonadism

August 4th 2022

Novel testosterone undecanoate capsule launched in US hypogonadism market
Novel testosterone undecanoate capsule launched in US hypogonadism market

June 9th 2022

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.